Literature DB >> 18424170

Characterization of detergent purified recombinant rat liver monoamine oxidase B expressed in Pichia pastoris.

Anup K Upadhyay1, Dale E Edmondson.   

Abstract

The high level expression and purification of rat monoamine oxidase B (rMAOB) in the methylotrophic yeast Pichia pastoris is reported. Nearly 100 mg of purified rMAOB is obtained from 130 g (wet weight) of cells (0.5 L of culture). The MALDI-TOF mass spectrum of the purified protein shows a single species with a molecular mass of 59.228 +/- 0.064 kDa, which agrees with the calculated molecular weight of 59.172 kDa for the rMAOB protein sequence assuming one mole of covalent FAD per mole of the enzyme. Consistent with the MALDI-MS data, purified rMAOB shows a single band near 60 kDa in Coomassie-stained SDS-PAGE gel as well as on Western blot analyses performed using antisera raised against human MAOA and BSA-conjugated FAD. A partial amino acid sequence of the purified protein is confirmed to be that of the wild type rMAOB by in-gel trypsin digestion and MALDI-TOF-MS analyses of the liberated peptide fragments. Steady state kinetic data show that purified rMAOB exhibits a K(m)(amine) of 176 +/- 15 microM and a k(cat) of 497 +/- 83 min(-1) for benzylamine oxidation, and a K(m)(O2) of 170 +/- 10 microM. Kinetic parameters obtained for purified rMAOB are compared with those reported earlier for recombinant human liver MAOB expressed in P. pastoris.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424170      PMCID: PMC2445446          DOI: 10.1016/j.pep.2008.03.002

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  24 in total

1.  High-level expression of human liver monoamine oxidase A in Pichia pastoris: comparison with the enzyme expressed in Saccharomyces cerevisiae.

Authors:  Min Li; Frantisĕk Hubálek; Paige Newton-Vinson; Dale E Edmondson
Journal:  Protein Expr Purif       Date:  2002-02       Impact factor: 1.650

2.  Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders.

Authors:  Claudia Binda; Paige Newton-Vinson; Frantisek Hubálek; Dale E Edmondson; Andrea Mattevi
Journal:  Nat Struct Biol       Date:  2002-01

Review 3.  Heterologous protein expression in the methylotrophic yeast Pichia pastoris.

Authors:  J L Cereghino; J M Cregg
Journal:  FEMS Microbiol Rev       Date:  2000-01       Impact factor: 16.408

4.  Quantitation of submicrogram quantities of protein by an improved protein-dye binding assay.

Authors:  J C Bearden
Journal:  Biochim Biophys Acta       Date:  1978-04-26

5.  High-level expression of human liver monoamine oxidase B in Pichia pastoris.

Authors:  P Newton-Vinson; F Hubalek; D E Edmondson
Journal:  Protein Expr Purif       Date:  2000-11       Impact factor: 1.650

6.  Biosynthesis and regulation of the peroxisomal methanol oxidase from the methylotrophic yeast Hansenula polymorpha.

Authors:  R Roggenkamp; Z Janowicz; B Stanikowski; C P Hollenberg
Journal:  Mol Gen Genet       Date:  1984

7.  Import of proteins into mitochondria. Cytochrome b2 and cytochrome c peroxidase are located in the intermembrane space of yeast mitochondria.

Authors:  G Daum; P C Böhni; G Schatz
Journal:  J Biol Chem       Date:  1982-11-10       Impact factor: 5.157

8.  Oxidative alpha-ketoglutarate dehydrogenase inhibition via subtle elevations in monoamine oxidase B levels results in loss of spare respiratory capacity: implications for Parkinson's disease.

Authors:  M Jyothi Kumar; David G Nicholls; Julie K Andersen
Journal:  J Biol Chem       Date:  2003-09-08       Impact factor: 5.157

9.  Comparison of the structural properties of the active site cavities of human and rat monoamine oxidase A and B in their soluble and membrane-bound forms.

Authors:  Anup K Upadhyay; Jin Wang; Dale E Edmondson
Journal:  Biochemistry       Date:  2007-12-20       Impact factor: 3.162

10.  Early and persistent alterations in prefrontal cortex MAO A and B in Alzheimer's disease.

Authors:  B P Kennedy; M G Ziegler; M Alford; L A Hansen; L J Thal; E Masliah
Journal:  J Neural Transm (Vienna)       Date:  2003-07       Impact factor: 3.575

View more
  7 in total

1.  Interactions of monoamine oxidases with the antiepileptic drug zonisamide: specificity of inhibition and structure of the human monoamine oxidase B complex.

Authors:  Claudia Binda; Milagros Aldeco; Andrea Mattevi; Dale E Edmondson
Journal:  J Med Chem       Date:  2010-12-22       Impact factor: 7.446

2.  Topological probes of monoamine oxidases A and B in rat liver mitochondria: inhibition by TEMPO-substituted pargyline analogues and inactivation by proteolysis.

Authors:  Jin Wang; Dale E Edmondson
Journal:  Biochemistry       Date:  2011-03-07       Impact factor: 3.162

3.  Catalytic and inhibitor binding properties of zebrafish monoamine oxidase (zMAO): comparisons with human MAO A and MAO B.

Authors:  Milagros Aldeco; Betül Kacar Arslan; Dale E Edmondson
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2011-02-23       Impact factor: 2.231

4.  Potentiation of ligand binding through cooperative effects in monoamine oxidase B.

Authors:  Daniele Bonivento; Erika M Milczek; G Reid McDonald; Claudia Binda; Andrew Holt; Dale E Edmondson; Andrea Mattevi
Journal:  J Biol Chem       Date:  2010-09-20       Impact factor: 5.157

5.  Radiochemical Assay of Monoamine Oxidase Activity.

Authors:  Andrew Holt
Journal:  Methods Mol Biol       Date:  2023

6.  Expression of zebrafish (Danio rerio) monoamine oxidase (MAO) in Pichia pastoris: purification and comparison with human MAO A and MAO B.

Authors:  Betül Kacar Arslan; Dale E Edmondson
Journal:  Protein Expr Purif       Date:  2010-01-14       Impact factor: 1.650

7.  5-(5-Aryl-1,3,4-oxadiazole-2-carbonyl)furan-3-carboxylate and new cyclic C-glycoside analogues from carbohydrate precursors with MAO-B, antimicrobial and antifungal activities.

Authors:  Mohamed Mohamed El-Sadek; Seham Yassen Hassan; Nagwa Said Abd El-Dayem; Galila Ahmed Yacout
Journal:  Molecules       Date:  2012-06-07       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.